Abstract
Purpose:In vitro fertilization had been previously suggested by us as a means of “rescue” for patients with imminent ovarian hyperstimulation syndrome (OHSS) during treatment with human menopausal gonadotropin (hMG). We evaluated the pregnancy rate of rescued IVF cycles.
Methods:During the years 1994–1995, women treated with hMG and at risk of developing OHSS were referred to our IVF unit. Their estradiol level was above 1500 pg/ml, and eight or more follicles were observed by ultrasonography In all the patients. These high responders were offered the option to undergo ovum aspiration. We report the pregnancy rate in this group of patients.
Results:Thirty-nine women were referred to our unit for rescue IVF. Two were uneligible due to high progesterone concentrations. Thirty-seven women underwent ovum pickup and 32 had embryo transfer. The clinical pregnancy rate was 40% (13/32). Only two women had clinical OHSS.
Conclusions:We suggest that rescue IVF may be considered in hMG cycles of high responders with imminent OHSS. Rescue IVF offers a high rate of conception, avoids high-order multiple pregnancy, and appears not to increase the risk of OHSS in these women.
Keywords: ovarian hyperstimulation syndrome, rescue in vitro fertilizations, human menopausal gonadotropin
Full Text
The Full Text of this article is available as a PDF (262.3 KB).
REFERENCES
- 1.Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes JM. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril. 1991;56:213–220. [PubMed] [Google Scholar]
- 2.Lessing JB, Amit A, Libal Y, Yovel I, Kogosovski A, Peyser MP. Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization-embryo transfer. Fertil Steril. 1991;56:75–78. doi: 10.1016/s0015-0282(16)54420-3. [DOI] [PubMed] [Google Scholar]
- 3.Balasch J, Tur R, Creus M, Buxaderas R, Fabregues F, Balllesca JL, Barri PN, Vanrell JA. Triggering of ovulation by gonadotropin releasing hormone agonist in gonadotropin stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy. Gynecol Endocrinol. 1994;8:7–12. doi: 10.3109/09513599409028451. [DOI] [PubMed] [Google Scholar]
- 4.Itskovitz-Eldor J, Levron J, Kol S. Use of gonadotropin releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndrome. Clin Obstet Gynecol. 1994;36:701–710. doi: 10.1097/00003081-199309000-00026. [DOI] [PubMed] [Google Scholar]
- 5.Wada I, Matson PL, Troup SA, Hughes S, Buck P, Lieberman BA. Outcome of treatment subsequent to the elective cryopreservation of all embryos from women at risk of the ovarian hyperstimulation syndrome. Hum Reprod. 1992;7:962–966. doi: 10.1093/oxfordjournals.humrep.a137779. [DOI] [PubMed] [Google Scholar]
- 6.Bergh C, Bryman I, Nilsson L, Janson PO. Results of gonadotropin stimulation with the option to convert cycles to in vitri fertilization in cases of multifollicular development. Acta Obstet Gynecol Scand. 1998;77:68–73. doi: 10.1034/j.1600-0412.1998.770115.x. [DOI] [PubMed] [Google Scholar]
- 7.Van der Meer S, Gerris J, Joostens M, Tas B. Triggering of ovulation using gonadotropin releasing hormone agonist does not prevent ovarian hyperstimulation syndrome. Hum Reprod. 1993;8:1628–1631. doi: 10.1093/oxfordjournals.humrep.a137903. [DOI] [PubMed] [Google Scholar]